AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Feb 10, 2021
29821_dirs_2021-02-10_f263eab5-6cd8-4e02-8c27-ddb73a1b82ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-02-08
Reporting Person: Butcher Arthur C (EVP&Pres, Asia Pacific)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-08 | Common Stock | M | 9000.0000 | $13.0800 | Acquired | 45025.0000 | Direct |
| 2021-02-08 | Common Stock | S | 16902.0000 | $39.3925 | Disposed | 28123.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-08 | Stock Option (Right to Buy) | $13.0800 | M | 9000.0000 | Disposed | 2024-02-24 | Common Stock (9000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2555.0000 | Indirect |
Footnotes
F1: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.3611 to $39.4201, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.